Basf Se Corporation

Novartis Ag

Phillips-Medisize A/s

Basf Aktiengesellschaft

Meda Pharma Sarl

Novartis Pharma Gmbh

Basf Schweiz Ag

Stefan Hirsch

Thomas Wettling

Jan Olesen

Esben Weldingh Johansen

Hans Jensen

Peter Mathiasen

Markus Brym

Markus Weis

Klaus Muehlbach

Martin Reif

Oskar Michael Kalb

Andreas Eichfelder

Rainer Erhardt

Dov Tamarkin

Doron Friedman

Meir Eini

Helmut Mach

Georg Sieder

Guenter Scherr

Hans Schupp

Günter Scherr

Andreas Daiss

Hannah Maria Koenig

Hermann Ascherl

Frank-Olaf Mähling

Peter Spang

Wolfgang Kasel

Rosa Corberan Roc

Andreas Bauder

Joerg Schneider

Jürgen Ciprian

Anja Vinckier

Hannah Maria König

Sabine Desset-Brethes

Regis Frelon

Robert Haschick

Alain Robert

Anton Stütz

Peter Pietzonka

Thomas Holtmann

Juergen Ciprian

Irene Trötsch-Schaller

Uwe Rachwalsky

Jörg Schneider

Danielle Giron

Friedrich Karl Mayer

Jean-Daniel Bonny

Nabila Sekkat

Jean-Louis Reber

Marco-Christian Volland

Rainer Urban

Sabine Meyenburg

Dieter Becker

Christel Hittinger

Anne Berg

Rainer Alles

Ernst Ulrich Kölle

Stephan Hoffmann

Siegfried Willert

Klaus MÜHLBACH

Matthias Frohberger

Peter SCHÄFFLER

Rainer Ehrhardt

Anthony Williams

The invention relates to a dispensing device for metering and dispensing a predetermined number of multiparticulates from a container. The dispensing device comprises a chamber which includes an inlet through which multiparticulates can enter the chamber and an overflow through which multiparticulates can leave the chamber. There is also an outlet through which multiparticulates can be dispensed from the chamber. The chamber comprises a metering surface which includes at least one retaining portion. The, or each, of the retaining portions is configured to be able to releasably retain a single multiparticulate.

Dispensing device

Continuous preparation of polyisobutylene having a content of terminal double bonds of more than 50% by polymerizing isobutene in the presence of a polymerization catalyst customary therefor, by combining a technical 1-butene-, 2-butene- and isobutene-containing Chydrocarbon stream together with a stream of pure isobutene and feeding them into the reaction zone in such a way that the steady-state concentration of the isobutene in the combined stream at the feed point of the combined stream into the reaction zone has an average value of at least 40% by weight, and a polymerization plant therefor.

Process for continuously preparing polyisobutylene

Pill dispenser

Preparation of isobutene homopolymers having a weight-average molecular weight of 75 000 to 10 000 000 by polymerization of isobutene, by

Process for preparing higher molecular weight polyisobutylene

A polyisobutylene having a total content of vinylidene double bonds of more than 50 mol % and a number-average molecular weight of 500 to 10 000 daltons, where at least 10% of all the vinylidene double bonds in the polyisobutylene are part of one or more side chains composed of at least 2 carbon atoms from the main polyisobutylene chain. Such a polyisobutylene is suitable for production of fuel and lubricant additives.

High-reactivity polyisobutylene having a high content of vinylidene double bonds in the side chains

Preparation of isobutene homopolymers or copolymers having a number average molecular weight of from 500 to 5 000 000 by polymerization of isobutene or an isobutene-comprising monomer mixture in the presence of a Lewis acid or a complex comprising a Lewis acid as polymerization catalyst, wherein the polymerization is carried out in the presence of at least one hemiacetal or full acetal which can be obtained by protic acid-catalyzed reaction of at least one C-C-hydrocarbyl alcohol with at least one aldehyde or ketone having from 1 to 12 carbon atoms.

Process for preparing isobutene homopolymers or copolymers

Pharmaceutical foam compositions substantially free of ethanol and comprising pimecrolimus in a carrier vehicle comprising a mixture of oily solvents amounting to at least 40% of the total weight of the composition and consisting of: They are indicated for use in the treatment of various skin, nail and mucosal diseases.

Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

A catalyst complex composed of boron trifluoride and a cocatalyst mixture of 10 to 90% by weight of a monohydric primary C- to C-alcohol and 90 to 10% by weight of a monohydric secondary C- to C-alcohol, where the molar ratio of boron trifluoride to the sum of all alcohols is 2:1 to 1:10. This catalyst complex is used in the preparation of high-reactivity isobutene homopolymers having a number-average molecular weight of 300 to 50 000, using, as the feedstock, a Chydrocarbon mixture comprising at least 20% by weight of isobutene and a total of at least 10% by weight of other Colefins.

Boron trifluoride-catalyst complex and process for preparing high-reactivity isobutene homopolymers

The invention relates to a process for preparing polymethylolated melamine and polymethylolated melamine compounds polyetherified with alkanol, wherein the methylolation reaction is carried out in a kneading reactor.

Continuous method for producing highly methylolated melamine and etherified melamine formaldehyde resins

The invention relates to a process for preparing free-flowing, pulverulent alkoxycarbonylaminotriazine from an alkanolic reaction mixture which is obtained in the preparation of alkoxycarbonylaminotriazines and comprises at least one alkoxycarbonylaminotriazine, at least one cyclic and/or acyclic carbonic ester, at least one C-C-alkanol which optionally comprises one or two oxygen atoms in the form of ether bonds and is optionally substituted by C-C-alkyl and/or hydroxyl, and also at least one alkali metal or alkaline earth metal alkoxide, with or without melamine and with or without catalyst, by atomizing and drying the reaction mixture in a spray drier.

Process for the preparation of pulverulent alkoxycarbonylaminotriazine

The invention concerns salts of the compound of formula I with malic acid, their preparation, corresponding pharmaceutical compositions and their use as antimycotics.

Malic acid addition salts of terbinafine

Combined capsule and tablets

Growing community of inventors

Lorrach, Germany

Stefan Hirsch